Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F

被引:37
作者
Ulenga, Nzovu K. [1 ]
Sarr, Abdoulaye Dieng [1 ]
Thakore-Meloni, Seema [1 ]
Sankale, Jean-Louis [1 ]
Eisen, Geoff [1 ]
Kanki, Phyllis J. [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
关键词
D O I
10.1086/590212
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Human immunodeficiency virus type 1 (HIV-1)-infected individuals with a high viral set point progress to acquired immunodeficiency syndrome (AIDS) more rapidly than those with a low viral set point. It is not entirely clear which host and viral factors are responsible for the viral set point. Host factors that affect virus replication are likely to influence the viral set point. Human APOBEC proteins have been shown to restrict HIV-1 replication. Methods. This prospective study was conducted to determine the relationship between human APOBEC3G (hA3G) and APOBEC3F (hA3F) levels and the viral set point. Fourteen subjects were classified as having a high viral set point, and 16 were classified as having a low viral set point. We quantified the levels of hA3G and hA3F mRNA in HIV-1-infected, antiretroviral drug-naive individuals before and after infection. Results. We found a significant correlation between the hA3G mRNA level and the viral set point. The expression of hA3G and hA3F increased after infection, and the levels of hA3G and hA3F mRNA were significantly higher after infection in the low viral set point group, compared with the high viral set point group. Conclusions. The results suggest that the level of hA3G expression affects the establishment of the viral set point and may therefore function as a host determinant in the pathogenesis of HIV-1 infection.
引用
收藏
页码:486 / 492
页数:7
相关论文
共 49 条
[1]   Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes:: Correlation with mutation spectra in vivo [J].
Beale, RCL ;
Petersen-Mahrt, SK ;
Watt, IN ;
Harris, RS ;
Rada, C ;
Neuberger, MS .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 337 (03) :585-596
[2]   Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals [J].
Biasin, Mara ;
Piacentini, Luca ;
Lo Caputo, Sergio ;
Kanari, Yasuyoshi ;
Magri, Giuliana ;
Trabattoni, Daria ;
Naddeo, Valentina ;
Lopalco, Lucia ;
Clivio, Alberto ;
Cesana, Eugenio ;
Fasano, Francesca ;
Bergamaschi, Cristina ;
Mazzotta, Francesco ;
Miyazawa, Masaaki ;
Clerici, Mario .
JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (07) :960-964
[3]   Rapid clearance of virus after acute HIV-1 infection: Correlates of risk of AIDS [J].
Blattner, WA ;
Oursler, KA ;
Cleghorn, F ;
Charurat, M ;
Sill, A ;
Bartholomew, C ;
Jack, N ;
O'Brien, T ;
Edwards, J ;
Tomaras, G ;
Weinhold, K ;
Greenberg, M .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (10) :1793-1801
[4]   HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].
Carrington, M ;
Nelson, GW ;
Martin, MP ;
Kissner, T ;
Vlahov, D ;
Goedert, JJ ;
Kaslow, R ;
Buchbinder, S ;
Hoots, K ;
O'Brien, SJ .
SCIENCE, 1999, 283 (5408) :1748-1752
[5]   Alpha interferon potently enhances the anti-human immunodeficiency virus type I activity of APOBEC3G in resting primary CD4 T cells [J].
Chen, Keyang ;
Huang, Jialing ;
Zhang, Chune ;
Huang, Sophia ;
Nunnari, Giuseppe ;
Wang, Feng-xiang ;
Tong, Xiangrong ;
Gao, Ling ;
Nikisher, Kristi ;
Zhang, Hui .
JOURNAL OF VIROLOGY, 2006, 80 (15) :7645-7657
[6]   RETRACTED: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells (Retracted Article. See vol 466, pg 276, 2010) [J].
Chiu, YL ;
Soros, VB ;
Kreisberg, JF ;
Stopak, K ;
Yonemoto, W ;
Greene, WC .
NATURE, 2005, 435 (7038) :108-114
[7]   APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count [J].
Cho, SJ ;
Drechsler, H ;
Burke, RC ;
Arens, MQ ;
Powderly, W ;
Davidson, NO .
JOURNAL OF VIROLOGY, 2006, 80 (04) :2069-2072
[8]   HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].
CLARK, SJ ;
SAAG, MS ;
DECKER, WD ;
CAMPBELLHILL, S ;
ROBERSON, JL ;
VELDKAMP, PJ ;
KAPPES, JC ;
HAHN, BH ;
SHAW, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960
[9]  
DONNELLY C, 1993, B MATH BIOL, V55, P731, DOI 10.1007/BF02460671
[10]   KINETICS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) DNA AND RNA-SYNTHESIS DURING PRIMARY HIV-1 INFECTION [J].
GRAZIOSI, C ;
PANTALEO, G ;
BUTINI, L ;
DEMAREST, JF ;
SAAG, MS ;
SHAW, GM ;
FAUCI, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6405-6409